clinical experience with regorafenib in hcc
Published 7 years ago • 220 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
7:46
clinical use of regorafenib in mhcc
-
7:01
global use of regorafenib in hcc
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
8:29
incorporating regorafenib in the hcc treatment landscape
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
2:04
dr. bruix on regorafenib in second-line hcc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
8:25
key takeaway 4: second-line regorafenib after tki in hcc
-
1:51
managing side effects with regorafenib in hcc
-
2:02
dr. bruix discusses the application of regorafenib in hcc
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
5:31
practical advice for using regorafenib
-
9:34
regorafenib in colorectal cancer
-
7:09
global use of regorafenib in hcc
-
1:15
regonext: 2l regorafenib in patients with unresectable hcc who have progressed on atezo-bev